BeyondSpring Pharmaceuticals

BeyondSpring Pharmaceuticals

NJ - Florham Park
Pharmaceutical1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Small Molecules

BeyondSpring Pharmaceuticals is a life sciences company focused on Small Molecules.

Neurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT02812667Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Phase 1
Nivolumab
Lung Cancer
Phase 1/2
Phase 2
Clinical Trials (1)
NCT05130827Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
Phase 2
Phase 2
Clinical Trials (1)
NCT04345900Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2
Phase 2
Phase 2
Clinical Trials (1)
NCT04227990Plinabulin iv Solution in Prevention of TAC Induced Neutropenia
Phase 2
Pembrolizumab in Combination with Plinabulin and Docetaxel
Non Small Cell Lung Cancer Metastatic
Phase 2
Docetaxel + Plinabulin
Non-Small Cell Lung Cancer
Phase 3
Clinical Trials (1)
NCT02504489Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC
Phase 3
Phase 3
Clinical Trials (1)
NCT07361484Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)
Phase 3
Phase 3
Clinical Trials (1)
NCT03102606Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
Phase 3
Phase 3
Clinical Trials (1)
NCT03294577Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2014
Portfolio: 8 clinical trials
H-1B (2023): 1 approval

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub